Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of California San Francisco
Research
Protein interactions shed new light on causes of autism
Studying protein-protein interactions might hold the key to identifying druggable targets for autism, a group of scientists at UCSF have suggested.
Marissa Russo
Aug 27, 2026 2:00pm
Center launches with $20M to create CRISPR therapies for kids
Jul 8, 2025 11:59am
ASGCT: Addressing the ethical issues of prenatal gene therapy
May 14, 2024 4:30am
Using cancer's 'superpower' to boost T-cell therapies in mice
Feb 12, 2024 3:30pm
Chromosome loss from CRISPR-Cas9 stopped by swapping steps
Oct 9, 2023 7:40am
AbbVie continues Parkinson's pursuit with $110M Mitokinin buy
Oct 5, 2023 10:30am
